Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zen-Zen Globalwide Biotech is a Taiwan-based biotechnology company specializing in regenerative medicine and immune cell therapies. The company focuses on the development and application of stem cell and immune cell technologies for treating degenerative diseases and various forms of cancer. Zen-Zen provides comprehensive cell banking services and is actively involved in clinical research to advance personalized medicine through autologous and allogeneic cell products. Their core mission involves leveraging advanced cell processing techniques to improve patient outcomes in the fields of oncology, orthopedics, and anti-aging. The company operates within the regulatory framework of Taiwan's Special Medical Act to provide advanced therapeutic options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zen-Zen Globalwide Biotech.